264 related articles for article (PubMed ID: 23264146)
1. Lurasidone : in the treatment of schizophrenia.
Sanford M
CNS Drugs; 2013 Jan; 27(1):67-80. PubMed ID: 23264146
[TBL] [Abstract][Full Text] [Related]
2. Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
De Hert M; Yu W; Detraux J; Sweers K; van Winkel R; Correll CU
CNS Drugs; 2012 Sep; 26(9):733-59. PubMed ID: 22900950
[TBL] [Abstract][Full Text] [Related]
3. Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?
Citrome L
Clin Schizophr Relat Psychoses; 2012 Jul; 6(2):76-85. PubMed ID: 22776634
[TBL] [Abstract][Full Text] [Related]
4. Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.
Citrome L
Int J Clin Pract; 2011 Feb; 65(2):189-210. PubMed ID: 21129135
[TBL] [Abstract][Full Text] [Related]
5. Lurasidone: a new treatment option for schizophrenia.
Owen RT
Drugs Today (Barc); 2011 Nov; 47(11):807-16. PubMed ID: 22146224
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: a randomized, double-blind, placebo- and active-controlled trial.
Loebel A; Cucchiaro J; Sarma K; Xu L; Hsu C; Kalali AH; Pikalov A; Potkin SG
Schizophr Res; 2013 Apr; 145(1-3):101-9. PubMed ID: 23415311
[TBL] [Abstract][Full Text] [Related]
7. Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study.
Meltzer HY; Cucchiaro J; Silva R; Ogasa M; Phillips D; Xu J; Kalali AH; Schweizer E; Pikalov A; Loebel A
Am J Psychiatry; 2011 Sep; 168(9):957-67. PubMed ID: 21676992
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.
McEvoy JP; Citrome L; Hernandez D; Cucchiaro J; Hsu J; Pikalov A; Loebel A
J Clin Psychiatry; 2013 Feb; 74(2):170-9. PubMed ID: 23473350
[TBL] [Abstract][Full Text] [Related]
9. Iloperidone, asenapine, and lurasidone: a brief overview of 3 new second-generation antipsychotics.
Citrome L
Postgrad Med; 2011 Mar; 123(2):153-62. PubMed ID: 21474903
[TBL] [Abstract][Full Text] [Related]
10. Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study.
Ogasa M; Kimura T; Nakamura M; Guarino J
Psychopharmacology (Berl); 2013 Feb; 225(3):519-30. PubMed ID: 22903391
[TBL] [Abstract][Full Text] [Related]
11. [Short-term efficacy and safety of lurasidone in the treatment of schizophrenia].
Samalin L; Ben Gharbia M; Garnier M; Llorca PM
Encephale; 2014 Dec; 40(6):507-17. PubMed ID: 25453735
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of lurasidone for patients with schizophrenia following 6 weeks of acute treatment with lurasidone, olanzapine, or placebo: a 6-month, open-label, extension study.
Stahl SM; Cucchiaro J; Simonelli D; Hsu J; Pikalov A; Loebel A
J Clin Psychiatry; 2013 May; 74(5):507-15. PubMed ID: 23541189
[TBL] [Abstract][Full Text] [Related]
13. Lurasidone in schizophrenia: new information about dosage and place in therapy.
Citrome L
Adv Ther; 2012 Oct; 29(10):815-25. PubMed ID: 23001538
[TBL] [Abstract][Full Text] [Related]
14. Effect of lurasidone on neurocognitive performance in patients with schizophrenia: a short-term placebo- and active-controlled study followed by a 6-month double-blind extension.
Harvey PD; Siu CO; Hsu J; Cucchiaro J; Maruff P; Loebel A
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1373-82. PubMed ID: 24035633
[TBL] [Abstract][Full Text] [Related]
15. Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia.
Loebel AD; Siu CO; Cucchiaro JB; Pikalov AA; Harvey PD
CNS Spectr; 2014 Apr; 19(2):197-205. PubMed ID: 24330860
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: a 12-month, double-blind, noninferiority study.
Loebel A; Cucchiaro J; Xu J; Sarma K; Pikalov A; Kane JM
Schizophr Res; 2013 Jun; 147(1):95-102. PubMed ID: 23583011
[TBL] [Abstract][Full Text] [Related]
17. Lurasidone for schizophrenia: what's different?
Kantrowitz JT; Citrome L
Expert Rev Neurother; 2012 Mar; 12(3):265-73. PubMed ID: 22364325
[TBL] [Abstract][Full Text] [Related]
18. Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled study.
Nasrallah HA; Silva R; Phillips D; Cucchiaro J; Hsu J; Xu J; Loebel A
J Psychiatr Res; 2013 May; 47(5):670-7. PubMed ID: 23421963
[TBL] [Abstract][Full Text] [Related]
19. Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial.
Nakamura M; Ogasa M; Guarino J; Phillips D; Severs J; Cucchiaro J; Loebel A
J Clin Psychiatry; 2009 Jun; 70(6):829-36. PubMed ID: 19497249
[TBL] [Abstract][Full Text] [Related]
20. Lurasidone for schizophrenia: a brief review of a new second-generation antipsychotic.
Citrome L
Clin Schizophr Relat Psychoses; 2011 Jan; 4(4):251-7. PubMed ID: 21177242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]